<?xml version="1.0" encoding="UTF-8"?><rss version="0.92">
<channel>
	<title>Synapcell &#187; News</title>
	<link>http://www.synapcell.fr</link>
	<description>Effective solutions for pre-clinical drug development in Epilepsy</description>
	<lastBuildDate>Fri, 22 Mar 2013 15:18:28 +0000</lastBuildDate>
	<docs>http://backend.userland.com/rss092</docs>
	<language>en</language>
	<!-- generator="WordPress/3.1" -->

	<item>
		<title>Antiepileptic Drug Trials XII Conference, 2013</title>
		<description><![CDATA[Antiepileptic Drug Trials XII Conference May 15-17 2013 Miami, Florida SynapCell will present its Drug Discovery &#038; Development solutions during the Anti-Epileptic Drugs and Device Trials This is the twelfth conference focusing on issues related to antiepileptic drug (AED) development from preclinical discoveries through clinical evaluations. This symposium will bring together representatives from academia, industry, [...]]]></description>
		<link>http://www.synapcell.fr/news/antiepileptic-drug-trials-xii-conference-2013</link>
			</item>
	<item>
		<title>SynapCell Scientific Advisory Board meets to discuss advances in epilepsy treatment</title>
		<description><![CDATA[SynapCell Scientific Advisory Board meets to discuss advances in epilepsy treatment Grenoble, France, November 14, 2012 SynapCell leverages the expertise of three world-renowned epilepsy specialists Pr. H. Steve White of the United States and Pr. Philippe Kahane and Dr. Antoine Depaulis of France to continue to deliver drug development innovations in the field of epilepsy. [...]]]></description>
		<link>http://www.synapcell.fr/news/synapcell-scientific-advisory-board-meets-to-discuss-advances-in-epilepsy-treatment</link>
			</item>
	<item>
		<title>2012 American Epilepsy Society annual meeting</title>
		<description><![CDATA[American Epilepsy Society annual meeting San Diego November 30 &#8211; December 4, 2012 The 2012 American Epilepsy Society annual meeting will take place in San Diego from November 30 to December 4. It is the premiere meeting for epilepsy and other seizure disorders. The Congress is an international forum and gives the opportunity to exchange [...]]]></description>
		<link>http://www.synapcell.fr/news/2012-american-epilepsy-society-annual-meeting</link>
			</item>
	<item>
		<title>CTAD conference Monte Carlo</title>
		<description><![CDATA[Clinical Trials on Alzheimer&#8217;s Disease Monte Carlo, October 29-31, 2012 Alzheimer’s disease is one of the most important health challenges worldwide. The development of the next generation of Alzheimer’s disease drugs is becoming essential to face up to this challenge. New pathways have been identified with biomarkers, facilitating novel trial designs for studies of tau-based [...]]]></description>
		<link>http://www.synapcell.fr/non-classe/ctad-conference-monte-carlo</link>
			</item>
	<item>
		<title>10th European congress on Epileptology</title>
		<description><![CDATA[10th European congress on Epileptology London, September 30th – October 4th 2012 The program will cover cutting-edge research in the field of epilepsy through presentations from the leaders in the field, including lectures by world-renowned scientists on topics at the interfaces of epilepsy. Four main themes run through the program: basic and translational science; neuroimaging [...]]]></description>
		<link>http://www.synapcell.fr/news/10th-european-congress-on-epileptology</link>
			</item>
	<item>
		<title></title>
		<description><![CDATA[2012 BIO International Convention Boston, MA, June 18 – 21, 2012 We will be happy to meet you at the Global Event for Biotechnology. Booth 1043 &#8211; Hall A &#8211; France Pavilion 2012 BIO International Convention]]></description>
		<link>http://www.synapcell.fr/news/1488</link>
			</item>
	<item>
		<title>Eleventh Eilat conference on new antiepileptic drugs</title>
		<description><![CDATA[Eleventh Eilat conference on new antiepileptic drugs Eilat, Israel, May 6 – 10, 2012 The conference program is designed to provide an in-depth progress report on new antiepileptic drugs in different stages of development, as well as to present new findings on second-generation treatments. SynapCell will be presenting its chronic animal models of epilepsy and [...]]]></description>
		<link>http://www.synapcell.fr/news/eleventh-eilat-conference-on-new-antiepileptic-drugs</link>
			</item>
	<item>
		<title>American Epilepsy Society&#8217;s annual meating &#8211; 2011</title>
		<description><![CDATA[American Epilepsy Society’s Annual Meeting Baltimore, Maryland December 2-6, 2011 The American Epilepsy Society’s Annual Meeting is the nation’s premiere meeting for epilepsy and other seizure disorders. The Annual Meeting is an international forum for the exchange of current findings in epilepsy research. SynapCell will be presenting its chronic animal models of epilepsy and their [...]]]></description>
		<link>http://www.synapcell.fr/news/1424</link>
			</item>
	<item>
		<title>Press Release / November 23, 2011 &#8211; NeuroTherapeutics Pharma once again turns to SynapCell for its epilepsy drug project.</title>
		<description><![CDATA[NeuroTherapeutics Pharma once again turns to SynapCell for its epilepsy drug project Press Release / November 23, 2011 The US-based developer of therapies for neurological disorders has decided to further its groundbreaking work with SynapCell to test promising new epilepsy drugs. Grenoble, November 23, 2011 − SynapCell, an expert in assessing the efficacy of epilepsy [...]]]></description>
		<link>http://www.synapcell.fr/news/press-release-november-232011-neurotherapeutics-pharma-once-again-turns-to-synapcell-for-its-epilepsy-drug-project</link>
			</item>
	<item>
		<title>29th International Epilepsy Congress</title>
		<description><![CDATA[The 29th International Epilepsy Congress (IEC) will be held in the ancient city of Rome, from 28th August to 1st September 2011 Topics will explore and integrate the scientific and social aspects of the issues faced by physicians, carers, persons with epilepsy and by all others involved in the field of epilepsy. SynapCell will be [...]]]></description>
		<link>http://www.synapcell.fr/news/29th-international-epilepsy-congress</link>
			</item>
	<item>
		<title>April 19, 2011 &#8211; MedGenesis Therapeutix Selects SynapCell for Key Preclinical Epilepsy Research</title>
		<description><![CDATA[MedGenesis Therapeutix Selects SynapCell for Key Preclinical Epilepsy Research April 19, 2011 MedGenesis Therapeutix Inc., which develops and commercializes innovative treatments for patients with serious neurological diseases, has selected SynapCell to provide animal proof of concept for its lead product, GDNF, in chronic epilepsy. Grenoble, France – April 19, 2011 – Grenoble, France-based biotechnology firm [...]]]></description>
		<link>http://www.synapcell.fr/news/april-19-2011-medgenesis-therapeutix-selects-synapcell-for-key-preclinical-epilepsy-research</link>
			</item>
	<item>
		<title>Antiepileptic Drug Trials XI Conference, 2011</title>
		<description><![CDATA[Antiepileptic Drug Trials XI Conference April 27-29, 2011 Aventura, North Miami Beach, Florida The eleventh conference will be held in Aventura, North Miami beach (April 27-29) and will focus on issues related to antiepileptic drug (AED) development from preclinical discoveries through clinical evaluations. This symposium will bring together representatives from academia, industry, the NIH, and [...]]]></description>
		<link>http://www.synapcell.fr/news/antiepileptic-drug-trials-xi-conference-2011</link>
			</item>
	<item>
		<title>American Epilepsy Society’s Annual Meeting, 2010</title>
		<description><![CDATA[American Epilepsy Society’s Annual Meeting December 3 &#8211; 7, 2010 San Antonio, TX The American Epilepsy Society&#8217;s Annual Meeting is the premiere meeting for epilepsy and other seizure disorders. The Annual Meeting is an international forum for the exchange of current findings in epilepsy research. SynapCell will be presenting its chronic animal models of epilepsy [...]]]></description>
		<link>http://www.synapcell.fr/news/american-epilepsy-society%e2%80%99s-annual-meeting-2010</link>
			</item>
	<item>
		<title>Monitoring Molecules in Neuroscience, 2010, Brussels</title>
		<description><![CDATA[13th International Conference on In vivo Methods Monitoring Molecules in Neuroscience September 12-16, 2010, Brussels, Belgium This conference will gather international academic and industrial researchers active in the field of experimental in vivo neuropharmacology and neurophysiology. Emphasis will be set upon state-of-the-art applications of neurochemical techniques ranging from studies conducted in single cells to those [...]]]></description>
		<link>http://www.synapcell.fr/news/monitoring-molecules-in-neuroscience-2010-brussels</link>
			</item>
	<item>
		<title>The 9th European Congress on Epileptology</title>
		<description><![CDATA[The 9th European Congress on Epileptology Rhodes, Greece. June 27-July 1, 2010 This meeting aims to reflect the current momentum in epileptology created by the challenge to translate the recent advances in basic neuroscience research, the emerging pathophysiology concepts and the powerful new diagnostic tools into better epilepsy patient care. SynapCell will be happy to [...]]]></description>
		<link>http://www.synapcell.fr/news/the-9th-european-congress-on-epileptology</link>
			</item>
	<item>
		<title>Eilat Conference on New Antiepileptic Drugs (EILAT X)</title>
		<description><![CDATA[Eilat conference on new antiepileptic drugs April 25-26, 2010 As in the past, the conference program is designed to provide an in-depth progress report on new antiepileptic drugs in different stages of development, as well as to present new findings on second-generation treatments. In addition, sessions will be devoted to: - Learning from the Past: [...]]]></description>
		<link>http://www.synapcell.fr/news/eilat-x-conference-new-antiepileptic-drugs</link>
			</item>
	<item>
		<title>Epilepsy Pipeline Update Conference</title>
		<description><![CDATA[Epilepsy Pipeline Update Conference Feb 25-26, 2010 The 2010 Epilepsy Pipeline Update Conference continues our tradition of showcasing new and promising treatments, with epilepsy as a portal into the broad CNS market. This in-depth meeting will focus on preclinical, early- and late-stage clinical development strategies, and investment and business development opportunities. Meet us at Hyatt [...]]]></description>
		<link>http://www.synapcell.fr/news/epilepsy-pipeline-update-conference</link>
			</item>
	<item>
		<title>American Epilepsy Society&#8217;s Annual Meeting 2009</title>
		<description><![CDATA[American Epilepsy Society&#8217;s Annual Meeting 2009 Dec 4-8, 2009 Today, at the 63th meeting of the American Epilepsy Society, a panel of international experts from developed and developing countries will offer a global consensus definition of treatment resistant epilepsy. In offering this new definition the global epilepsy community hopes to improve patient care and better [...]]]></description>
		<link>http://www.synapcell.fr/news/american-epilepsy-societys-annual-meeting-2009</link>
			</item>
	<item>
		<title>10th conference on Antiepileptic Drug Trials</title>
		<description><![CDATA[10th conference on Antiepileptic Drug Trials Apr 15-17, 2009 This is the tenth conference focusing on issues related to antiepileptic drug (AED) development from preclinical discoveries through clinical evaluations. In 2008 as many antiepileptic drugs are in the pipeline as at any time in the past. There is a always opportunity to learn from the [...]]]></description>
		<link>http://www.synapcell.fr/news/10th-conference-on-antiepileptic-drug-trials-2009</link>
			</item>
	<item>
		<title>Successful renewal of certification ISO 9001:2000</title>
		<description><![CDATA[Successful renewal of certification ISO 9001:2000 Mar 17, 2009 SynapCell, a biotech company based in Grenoble, specialised in preclinical evaluation of drug candidates dedicated to brain pathologies, obtained on the 5th of March the certification ISO9001:2000 for its activity of services and research in neurosciences after an audit by the independent organism SGS of the [...]]]></description>
		<link>http://www.synapcell.fr/news/successful-renewal-of-certification-iso-9001-2000</link>
			</item>
	<item>
		<title>SynapCell raises 700 000 euros for its first fundraising</title>
		<description><![CDATA[SynapCell raises 700 000€ for its first fundraising Mar 11, 2009 Specialised in the preclinical expertise of drug candidates dedicated to brain pathologies, announces the closing of its first fundraising with a total of 700 000 euros. The operation was realised with a group of investors, representing major actors of investment in Rhone Alpes. Rhône-Alpes [...]]]></description>
		<link>http://www.synapcell.fr/news/synapcell-raise-700000-euros-first-fundrais</link>
			</item>
	<item>
		<title>BioSquare Lyon 2009</title>
		<description><![CDATA[BioSquare Lyon 2009 March 9-11, 2009 We have made some hard choices. We took no aspect of the event for granted. What’s more, with some outside help, we managed to ask our participants and ourselves some tough questions. Their wishes and our instincts tell us that the industry wants efficiency and results, not a potpourri [...]]]></description>
		<link>http://www.synapcell.fr/news/biosquare-lyon-2009</link>
			</item>
	<item>
		<title>American Epilepsy Society&#8217;s Annual Meeting 2008</title>
		<description><![CDATA[American Epilepsy Society&#8217;s Annual Meeting 2008 Dec 5-9, 2008 AES 62nd Annual Meeting - 2nd Biennial North American Regional Epilepsy Congress The Annual Meeting of the American Epilepsy Society is the largest meeting and exhibition in the world of those who share the common scientific and clinical interests of epilepsy and clinical neurophysiology. Each year [...]]]></description>
		<link>http://www.synapcell.fr/news/american-epilepsy-societys-annual-meeting-2008</link>
			</item>
	<item>
		<title>EuroBIO 2008</title>
		<description><![CDATA[EuroBIO 2008 October 7-9, 2008 At the request of its prestigious International Steering Committee, and in view of EuroBiO&#8217;s nomination as the leading life sciences event of the rotating EU Presidency, the Organizing Committee was set two goals: • to send the attendees home charged with ideas and opportunities • to generate a snapshot of [...]]]></description>
		<link>http://www.synapcell.fr/news/eurobio-2008</link>
			</item>
</channel>
</rss>
